The Importance of Improving Healthcare’s Cyber Resilience

The Importance of Improving Healthcare’s Cyber Resilience

Listen Pause
Healthcare organizations have always needed to be prepared for unexpected events, from natural disasters to pandemic surges. Increasingly, cyberattacks must factor into their response plans, especially as threats grow more sophisticated and coordinated.
Ninety-six percent of executives across industries consider cyber resilience to be highly important to their businesses, according to a 2022 Cisco report. Nearly two-thirds of respondents said they experienced a security incident that affected their resilience, with a majority happening over the past two years.
As cyberattacks continue to make headlines, organizations should think in terms of…

Continue Reading
Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Surgical robotics is dominated by various versions of the da Vinci system from Intuitive Surgical, a competent but expensive tool that’s become a standard in modern advanced hospitals. It took Intuitive about 30 years to achieve this status, but there are systems from J&J, Medtronic, CMR Surgical, and others that are chipping away at the company’s dominance. All of these systems operate under the “master-slave” concept, which involves a surgeon sitting behind a console, away from the patient, who manipulates the mechanical arms of the robot via some kind of joystick-like device. Thanks to kind support from Biomed Israel, the leading…

Continue Reading
GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’

GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’

Vir Biotechnology’s Covid-19 research may yield more drugs and perhaps a vaccine, but no longer with the financial support of GSK. The collaboration agreement the two companies struck up in the early days of the pandemic has been amended, leaving Vir to either find another partner or continue its coronavirus research on its own.
The alliance did successfully develop the Covid-19 drug sotrovimab. GSK and Vir will continue to share responsibilities for that drug, which is available under the brand name Xevudy in more than 40 countries. The U.S. is no longer one of them. Last April, the FDA withdrew emergency authorization…

Continue Reading